• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-L-D4A对DNA聚合酶α的作用及机制

Effect and mechanism of beta-L-D4A on DNA polymerase alpha.

作者信息

Li Yan, Lin Ju-Sheng, Zhang Ying-Hui, Wang Xiao-Yan, Chang Ying, He Xing-Xing

机构信息

Institute of Liver Diseases, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Street, Wuhan 430030, Hubei Province, China.

出版信息

World J Gastroenterol. 2007 Dec 14;13(46):6243-8. doi: 10.3748/wjg.v13.i46.6243.

DOI:10.3748/wjg.v13.i46.6243
PMID:18069767
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4171237/
Abstract

AIM

To investigate the safety of beta-L-D4A on DNA polymerase alpha.

METHODS

Ion exchange chromatography was used to separate DNA polymerase alpha from crude extract of human Hela cells. Detailed kinetic parameters were determined for beta-L-D4A against DNA polymerase alpha.

RESULTS

DNA polymerase alpha was purified with 4% yield and 31000 units/mg specific activity. The Michaelis constant (Km = 3.22 micromol/L), 50% inhibition concentration (IC50 = 178.49 micromol/L) and inhibition constant (Ki = 126 micromol/L) of beta-L-D4A were determined by kinetic analysis.

CONCLUSION

beta-L-D4A is a more safe nucleoside for hepatitis B virus infection with a lower host toxicity.

摘要

目的

研究β-L-D4A对DNA聚合酶α的安全性。

方法

采用离子交换色谱法从人Hela细胞粗提物中分离DNA聚合酶α。测定了β-L-D4A针对DNA聚合酶α的详细动力学参数。

结果

以4%的产率和31000单位/毫克的比活性纯化了DNA聚合酶α。通过动力学分析确定了β-L-D4A的米氏常数(Km = 3.22微摩尔/升)、50%抑制浓度(IC50 = 178.49微摩尔/升)和抑制常数(Ki = 126微摩尔/升)。

结论

β-L-D4A是一种对乙型肝炎病毒感染更安全的核苷,宿主毒性较低。

相似文献

1
Effect and mechanism of beta-L-D4A on DNA polymerase alpha.β-L-D4A对DNA聚合酶α的作用及机制
World J Gastroenterol. 2007 Dec 14;13(46):6243-8. doi: 10.3748/wjg.v13.i46.6243.
2
Efficacies of beta-L-D4A against Hepatitis B virus in 2.2.15 cells.β-L-D4A对2.2.15细胞中乙型肝炎病毒的疗效。
World J Gastroenterol. 2008 Feb 28;14(8):1263-7. doi: 10.3748/wjg.14.1263.
3
[Effect and mechanism of beta-L-D4A (a novel nucleoside analog) against hepatitis B virus].
Zhonghua Gan Zang Bing Za Zhi. 2003 May;11(5):268-70.
4
[Synthesis of a novel L-nucleoside, beta-L-D4A and its inhibition on the replication of hepatitis B virus in vitro].[一种新型L-核苷β-L-D4A的合成及其对乙型肝炎病毒体外复制的抑制作用]
Yao Xue Xue Bao. 2005 Sep;40(9):825-9.
5
Inhibition of reverse transcriptase activity of hepatitis B virus polymerase by β-l-D4A-TP.β-l-D4A-TP对乙型肝炎病毒聚合酶逆转录酶活性的抑制作用。
Acta Virol. 2008;52(1):47-52.
6
Inhibition of hepatitis B virus by a novel L-nucleoside, beta-L-D4A and related analogues.新型L-核苷β-L-D4A及相关类似物对乙型肝炎病毒的抑制作用
World J Gastroenterol. 2003 Aug;9(8):1840-3. doi: 10.3748/wjg.v9.i8.1840.
7
[Inhibition of the replication of hepatitis B virus in vitro by a novel nucleoside analogue (beta-L-D4A)].
Zhonghua Gan Zang Bing Za Zhi. 2003 Jul;11(7):446.
8
Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.β-L-2',3'-二脱氧腺苷的双(叔丁基SATE)磷酸三酯的抗病毒活性及细胞内代谢,一种HIV和HBV复制的强效抑制剂
Antivir Chem Chemother. 2001 Mar;12(2):99-108. doi: 10.1177/095632020101200203.
9
Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus.
FEBS Lett. 1997 Jun 30;410(2-3):324-8. doi: 10.1016/s0014-5793(97)00616-9.
10
Enzymatic properties of the unnatural beta-L-enantiomers of 2',3'-dideoxyadenosine and 2',3'-didehydro-2',3'-dideoxyadenosine.
J Med Chem. 1997 Nov 21;40(24):3969-73. doi: 10.1021/jm9701482.

本文引用的文献

1
Intramuscular hepatitis B immunoglobulin (HBIG) and nucleosides for prevention of recurrent hepatitis B following liver transplantation: comparison with other HBIG regimens.肌肉注射乙型肝炎免疫球蛋白(HBIG)和核苷类药物预防肝移植后乙型肝炎复发:与其他HBIG方案的比较
Clin Transplant. 2007 Jul-Aug;21(4):510-7. doi: 10.1111/j.1399-0012.2007.00678.x.
2
Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells.阿扎胞苷及其他核苷类逆转录酶抑制剂对HepG2细胞线粒体DNA复制的影响。
Antiviral Res. 2007 Oct;76(1):68-74. doi: 10.1016/j.antiviral.2007.05.004. Epub 2007 Jun 21.
3
Treatment of chronic hepatitis B with the combination of pegylated interferon with lamivudine.聚乙二醇干扰素联合拉米夫定治疗慢性乙型肝炎。
Hepatol Res. 2007 Jul;37(s1):S55-61. doi: 10.1111/j.1872-034X.2007.00106.x.
4
Appropriate use of interferon for treatment of chronic hepatitis B.干扰素在慢性乙型肝炎治疗中的合理应用。
Hepatol Res. 2007 Jul;37(s1):S47-54. doi: 10.1111/j.1872-034X.2007.00105.x.
5
Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy.拉米夫定单药治疗及拉米夫定联合α干扰素治疗对既往α干扰素单药治疗无反应的HBeAg阴性慢性乙型肝炎
Acta Gastroenterol Belg. 2007 Jan-Mar;70(1):20-4.
6
N'-[2-(2-thiophene) ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a rationally designed non-nucleoside reverse transcriptase inhibitor compound with potent anti-HIV activity.
Arzneimittelforschung. 2007;57(5):278-85. doi: 10.1055/s-0031-1296619.
7
Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance.乙型肝炎病毒基因型的遗传特征作为干扰素诱导HBeAg清除的一个因素。
J Med Virol. 2007 Aug;79(8):1055-63. doi: 10.1002/jmv.20935.
8
In vitro susceptibility of adefovir-associated hepatitis B virus polymerase mutations to other antiviral agents.阿德福韦相关的乙型肝炎病毒聚合酶突变对其他抗病毒药物的体外敏感性。
Antivir Ther. 2007;12(3):355-62.
9
Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase.HIV-1逆转录酶中K65R与胸苷类似物突变之间双向拮抗作用的分子机制
AIDS. 2007 Jul 11;21(11):1405-14. doi: 10.1097/QAD.0b013e3281ac229b.
10
Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients.肝内乙肝病毒DNA作为HBeAg阳性慢性乙型肝炎患者抗病毒治疗疗效的预测指标
World J Gastroenterol. 2007 May 28;13(20):2878-82. doi: 10.3748/wjg.v13.i20.2878.